Dr. Sandi A. Kwee, M.D.
Nuclear Medicine (Nuclear Medicine Physician)
1301 Punchbowl St, Nuclear Medicine Dept.
Honolulu, HI 96813
Who else practices at this address →
Honolulu County includes primary care (9% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- University of Pittsburgh School of Medicine (1996)
- Years since graduation
- 30
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 11
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1996Medical school: University of Pittsburgh School of Medicine
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Nuclear Medicine Physician primary
HI license 10547 -
Internal Medicine Physician
HI license 10547 -
Nuclear Cardiology Physician
HI license 10547 -
Nuclear Imaging & Therapy Physician
HI license 10547
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- The Queens Medical Center Honolulu, HI
- North Hawaii Community Hospital, Inc Kamuela, HI
Medical groups
- Queens University Medical Group (614 clinicians)
- Queens North Hawaii Community Hospital (108 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 11
- Services billed
- 11
- Patients’ average age
- 79
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 3 companies reported 4 payments worth $354 in total to this clinician.
| Novo Nordisk Inc | $239 |
|---|---|
| Telix Pharmaceuticals | $97.22 |
| GE Healthcare | $17.74 |
| Food and Beverage | $354 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $52,075 in research payments for these studies, mostly to the institutions running them.
- An Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Standard of Care, Versus Standard of Care Alone, in Adult Male Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)
Novartis Pharmaceuticals Corporation
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.